A detailed history of Pinnacle Financial Partners Inc transactions in Organon & Co. stock. As of the latest transaction made, Pinnacle Financial Partners Inc holds 188 shares of OGN stock, worth $2,825. This represents 0.0% of its overall portfolio holdings.

Number of Shares
188
Previous 188 -0.0%
Holding current value
$2,825
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 03, 2023

SELL
$23.31 - $28.61 $46 - $57
-2 Reduced 1.05%
188 $5,000
Q3 2022

Oct 31, 2022

BUY
$23.4 - $34.25 $46 - $68
2 Added 1.06%
190 $4,000
Q2 2022

Jul 29, 2022

BUY
$31.66 - $38.9 $5,952 - $7,313
188 New
188 $6,000
Q1 2022

May 02, 2022

SELL
$30.45 - $39.36 $121 - $157
-4 Closed
0 $0
Q3 2021

Oct 26, 2021

SELL
$28.63 - $35.64 $973 - $1,211
-34 Reduced 89.47%
4 $0
Q2 2021

Jul 21, 2021

BUY
$28.45 - $38.0 $1,081 - $1,444
38 New
38 $1,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.82B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Pinnacle Financial Partners Inc Portfolio

Follow Pinnacle Financial Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Financial Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Financial Partners Inc with notifications on news.